Zobrazeno 1 - 10
of 966
pro vyhledávání: '"Verrijp K"'
Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
Autor:
van der Hoorn IAE; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., Martynova E; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands., Subtil B; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., Meek J; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., Verrijp K; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Textor J; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands., Flórez-Grau G; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., Piet B; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., van den Heuvel MM; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., de Vries IJM; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., Gorris MAJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, the Netherlands.
Publikováno v:
European journal of immunology [Eur J Immunol] 2024 Jan; Vol. 54 (1), pp. e2350616. Date of Electronic Publication: 2023 Oct 24.
Autor:
Bakkerus L; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Subtil B; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bontkes HJ; Department Laboratory Medicine, LGDO, Section Medical Immunology, Amsterdam, The Netherlands., Gootjes EC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reijm M; Department Laboratory Medicine, LGDO, Section Medical Immunology, Amsterdam, The Netherlands., Vullings M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Verrijp K; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Bokhorst JM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Woortman C; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Jonker MA; Department of IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands., van der Vliet HJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Verhoef C; Department of Surgery, ErasmusMC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Gorris MAJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries IJM; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Gruijl TD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Buffart TE; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Tauriello DVF; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2024 Jun 10; Vol. 13 (1), pp. 2361971. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).
Autor:
Weiss L; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Institute for Chemical Immunology, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., Classens R; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Schluck M; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., Grad E; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Dölen Y; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., van der Woude L; Department of Pathology, Radboudum, Geert Grooteplein 10, Nijmegen, GA 6525, The Netherlands., van Midden D; Department of Pathology, Radboudum, Geert Grooteplein 10, Nijmegen, GA 6525, The Netherlands., Maassen L; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Verrijp K; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., van Riessen K; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., van Dinther E; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Hagemann PM; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Figdor CG; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Institute for Chemical Immunology, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., Hammink R; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.
Publikováno v:
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 May 03; Vol. 7 (6), pp. 1874-1883. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
Autor:
Haddad TS; Radboud University Medical Center, Nijmegen, The Netherlands., van den Dobbelsteen L; Radboud University Medical Center, Nijmegen, The Netherlands., Öztürk SK; Radboud University Medical Center, Nijmegen, The Netherlands., Geene R; USEQ, CMM, University Medical Center Utrecht, Utrecht, The Netherlands., Nijman IJ; USEQ, CMM, University Medical Center Utrecht, Utrecht, The Netherlands., Verrijp K; Radboud University Medical Center, Nijmegen, The Netherlands., Jamieson NB; University of Glasgow, Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, Glasgow, UK., Wood C; University of Glasgow, Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, Glasgow, UK., van Vliet S; Radboud University Medical Center, Nijmegen, The Netherlands., Reuvers L; Radboud University Medical Center, Nijmegen, The Netherlands., Achouiti S; Radboud University Medical Center, Nijmegen, The Netherlands., Rutgers N; Radboud University Medical Center, Nijmegen, The Netherlands., Brouwer N; Radboud University Medical Center, Nijmegen, The Netherlands., Simmer F; Radboud University Medical Center, Nijmegen, The Netherlands., Zlobec I; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Lugli A; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Nagtegaal ID; Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
The Journal of pathology [J Pathol] 2023 Sep; Vol. 261 (1), pp. 19-27. Date of Electronic Publication: 2023 Jul 04.
Autor:
Gorris MAJ; Department of Medical BioSciences, Radboudumc; Division of Immunotherapy, Oncode Institute, Radboudumc; mark.gorris@radboudumc.nl., Martynova E; Department of Medical BioSciences, Radboudumc; Data Science, Institute for Computing and Information Sciences, Radboud University., Sweep MWD; Department of Medical BioSciences, Radboudumc; Department of Medical Oncology, Radboudumc., van der Hoorn IAE; Department of Medical BioSciences, Radboudumc; Department of Pulmonary Diseases, Radboudumc., Sultan S; Department of Medical BioSciences, Radboudumc; Data Science, Institute for Computing and Information Sciences, Radboud University., Claassens MJDE; Department of Medical BioSciences, Radboudumc., van der Woude LL; Department of Medical BioSciences, Radboudumc; Division of Immunotherapy, Oncode Institute, Radboudumc; Department of Pathology, Radboudumc., Verrijp K; Department of Medical BioSciences, Radboudumc; Division of Immunotherapy, Oncode Institute, Radboudumc; Department of Pathology, Radboudumc., Figdor CG; Department of Medical BioSciences, Radboudumc; Data Science, Institute for Computing and Information Sciences, Radboud University., Textor J; Department of Medical BioSciences, Radboudumc; Data Science, Institute for Computing and Information Sciences, Radboud University., de Vries IJM; Department of Medical BioSciences, Radboudumc.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2023 Aug 18 (198). Date of Electronic Publication: 2023 Aug 18.
Autor:
Weiss L; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Weiden J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Dölen Y; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Grad EM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Dinther EAW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Schluck M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Eggermont LJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Mierlo G; Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), 1015 CH Lausanne, Switzerland., Gileadi U; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom., Bartoló-Ibars A; Department of Immunology, Hospital Clinic, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer Villarroel 170, 08036 Barcelona, Spain., Raavé R; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands., Gorris MAJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Maassen L; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands., Verrijp K; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Valente M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Deplancke B; Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), 1015 CH Lausanne, Switzerland., Verdoes M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Benitez-Ribas D; Department of Immunology, Hospital Clinic, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer Villarroel 170, 08036 Barcelona, Spain., Heskamp S; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands., van Spriel AB; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Hammink R; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Publikováno v:
ACS nano [ACS Nano] 2023 Jul 11; Vol. 17 (13), pp. 12101-12117. Date of Electronic Publication: 2023 Jun 20.
Autor:
van Ravensteijn SG; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Hillebrandt-Roeffen MHS; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Weidema ME; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Nederkoorn MJL; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Gorris MAJ; Department of Tumor Immunology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Verrijp K; Department of Tumor Immunology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Kroeze LI; Department of Pathology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., de Bitter TJJ; Department of Pathology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., de Voer RM; Department of Human Genetics, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Flucke UE; Department of Pathology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Nov 30; Vol. 14 (23). Date of Electronic Publication: 2022 Nov 30.
Autor:
van der Woude LL; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Gorris MAJ; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Wortel IMN; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands., Creemers JHA; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Verrijp K; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Grünberg K; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., van den Heuvel MM; Department of Pulmonary Diseases, Radboudumc, Nijmegen, The Netherlands., Textor J; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands., Figdor CG; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands., Piet B; Department of Pulmonary Diseases, Radboudumc, Nijmegen, The Netherlands., Theelen WSME; Department of Pulmonology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vries IJM; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands jolanda.devries@radboudumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gorris MAJ; Tumor Immunology, Radboudumc, Nijmegen, The Netherlands.; Oncode Institute, Nijmegen, The Netherlands., van der Woude LL; Tumor Immunology, Radboudumc, Nijmegen, The Netherlands.; Oncode Institute, Nijmegen, The Netherlands.; Pathology, Radboudumc, Nijmegen, The Netherlands., Kroeze LI; Pathology, Radboudumc, Nijmegen, The Netherlands., Bol K; Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Verrijp K; Oncode Institute, Nijmegen, The Netherlands.; Pathology, Radboudumc, Nijmegen, The Netherlands., Amir AL; Pathology, Radboudumc, Nijmegen, The Netherlands., Meek J; Tumor Immunology, Radboudumc, Nijmegen, The Netherlands., Textor J; Department of Tumor Immunology, Radboudumc, Nijmegen, The Netherlands.; Data Science Group, Institute for Computing and Information Sciences, Radboud Universiteit, Nijmegen, The Netherlands., Figdor CG; Tumor Immunology, Radboudumc, Nijmegen, The Netherlands.; Oncode Institute, Nijmegen, The Netherlands., de Vries IJM; Tumor Immunology, Radboudumc, Nijmegen, The Netherlands jolanda.devries@radboudumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 May; Vol. 10 (5).